U.S. Markets open in 37 mins

Comparing the EPS Trajectory of FOLD and PTLA in Fiscal 2019

Margaret Patrick
Comparing the EPS Trajectory of FOLD and PTLA in Fiscal 2019

Amicus or Portola: Which Is the Best Bet in May?(Continued from Prior Part)First-quarter performanceIn the first quarter, Amicus Therapeutics (FOLD) reported non-GAAP EPS of -$0.39, a YoY fall of 39.29% and lower than the consensus estimate by